crc press - E-Lib FK UWKS

360 Cell-Penetrating Peptides: Processes and Applications
REFERENCES
1. Delihas, N., Rokita, S.E., and Zheng, P., Natural antisense RNA/target RNA interactions:
possible models for antisense oligonucleotide drug design, Nat. Biotechnol.,
15, 751, 1997.
2. Morishita, R. et al., A gene therapy strategy using a transcription factor decoy of the
E2F binding site inhibits smooth muscle proliferation in vivo, Proc. Natl. Acad. Sci.
U.S.A., 92, 5855, 1995.
3. Feeley, B.T. et al., Nuclear factor-kappaB transcription factor decoy treatment inhibits
graft coronary artery disease after cardiac transplantation in rodents, Transplantation,
70, 1560, 2000.
4. Ishibashi, H. et al., Sp1 decoy transfected to carcinoma cells suppresses the expression
of vascular endothelial growth factor, transforming growth factor beta1, and tissue
factor and also cell growth and invasion activities, Cancer Res., 60, 6531, 2000.
5. Kawamura, I. et al., Intravenous injection of oligodeoxynucleotides to the NF-kappaB
binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice, Gene
Ther., 8, 905, 2001.
6. Tomita, N. et al., Inhibition of TNF-alpha, induced cytokine and adhesion molecule.
Expression in glomerular cells in vitro and in vivo by transcription factor decoy for
NFkappaB, Exp. Nephrol., 9, 181, 2001.
7. Park, Y.G. et al., Reduction in cyclin D1/Cdk4/retinoblastoma protein signaling by
CRE-decoy oligonucleotide, Biochem. Biophys. Res. Commun., 281, 1213, 2001.
8. Deshpande, D. et al., Enhanced cellular uptake of oligonucleotides by EGF receptormediated
endocytosis in A549 cells, Pharm. Res., 13, 57, 1996.
9. Nakai, D. et al., Cellular uptake mechanism for oligonucleotides: involvement of
endocytosis in the uptake of phosphodiester oligonucleotides by a human colorectal
adenocarcinoma cell line, HCT-15, J. Pharmacol. Exp. Ther., 278, 1362, 1996.
10. Bennet, R.M. et al., The production and characterization of murine monoclonal antibodies
to a DNA receptor on human leukocytes, J. Immunol., 140, 2937, 1988.
11. Hefeneider, S.H. et al., Identification of a cell-surface DNA receptor and its association
with systemic lupus erythematosus, J. Invest. Dermatol., 94, 79S, 1990.
12. Francolini, M. et al., Evidence for nuclear internalization of exogenous DNA into
mammalian sperm cells, Mol. Reprod. Dev., 34, 133, 1993.
13. Zamecnik, P. et al., Electron micrographic studies of transport of oligodeoxynucleotides
across eukaryotic cell membranes, Proc. Natl. Acad. Sci. U.S.A., 91, 3156, 1994.
14. Goodarzi, G., Watabe, M., and Watabe, K., Binding of oligonucleotides to cell
membranes at acidic pH, Biochem. Biophys. Res. Commun., 181, 1343, 1991.
15. Akhtar, S. et al., The influence of polarized epithelial (Caco-2) cell differentiation on
the cellular binding of phosphodiester and phosphorothioate oligonucleotides, Antisense
Nucleic Acid Drug Dev., 6, 197, 1996.
16. Yakubov, L.A. et al., Mechanism of oligonucleotide uptake by cells: involvement of
specific receptors? Proc. Natl. Acad. Sci. U.S.A., 86, 6454, 1989.
17. Wu-Pong, S., Weiss, T.L., and Hunt, C.A., Antisense c-myc oligonucleotide cellular
uptake and activity, Antisense Res. Dev., 4, 155, 1994.
18. Wu-Pong, S., Weiss, T.L., and Hunt, C.A., Antisense c-myc oligodeoxyribonucleotide
cellular uptake, Pharm. Res., 9, 1010, 1992.
19. Nestle, F.O. et al., Cationic lipid is not required for uptake and selective inhibitory
activity of ICAM-1 phosphorothioate antisense oligonucleotides in keratinocytes, J.
Invest. Dermatol., 103, 569, 1994.